glp-1 obesity drug news october 2025 Novo, Lilly weight-loss drugs should be first option treatments, European doctors say GLP-1 weight loss drugs leave

A New Drug Application for ITCA 650 was submitted to the FDA in November 2016 [99]

5 female, 5 male) for a 12-week trial as follows: standard lab chow with stevia (Stevita Naturals, Kennendale, TX, USA), Western diet chow with stevia, standard lab chow with allulose, or Western diet chow with allulose

Duration of Benefit The health benefits of GLP-1R agonists are most pronounced within the first year of treatment, with significant improvements in glycated hemoglobin (HbA1c), body mass index (BMI), and cardiovascular outcomes

This delay, combined with increased calorie burning through thermogenesis, makes Semaglutide GLP-1 an effective tool for managing weight

I encourage you to try it yourself, especially if you are in medical affairs, R&D, or clinical education